NovoLog FDA approval date

The FDA approved NovoLog (Insulin Aspart, a rapid-acting human insulin analogue) on 7 Jun 2000.

FDA approval date
7 Jun 2000

Drug identity checked against registry records

Also recorded as Insulin Aspart, a rapid-acting human insulin analogue

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2000-06-07DayNovoLogFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA020986", "applicant_as_listed_by_fda": "NOVO NORDISK INC", "brand_names": ["NOVOLOG", "NOVOLOG FLEXPEN", "NOVOLOG FLEXTOUCH", "NOVOLOG INNOLET", "NOVOLOG PENFILL"], "active_ingredients": ["INSULIN ASPART RECOMBINANT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20000607", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026